David Keire
Advertisement
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles by David Keire
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Merck TROP2 ADC Meets Survival End Point in Gastroesophageal Cancer
2
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
3
Evotec, BMS Gain Second FDA IND Acceptance for Molecular Glue Degrader
4
FDA Approves First RNAi Therapeutic for Generalized Myasthenia Gravis
5

